Phase 4 Multiple Sclerosis, Relapsing-Remitting Clinical Trials
2 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–2 of 2 trials
Recruiting
Phase 4
Effects of Ocrelizumab Treatment on Immune Cells in Lymph Nodes in Multiple Sclerosis
Multiple Sclerosis, Relapsing-Remitting
University of California, San Francisco5 enrolled1 locationNCT06495593
Recruiting
Phase 4
B Cell Tailored Ocrelizumab Versus Standard Ocrelizumab in Relapsing Remitting Multiple Sclerosis
Multiple Sclerosis, Relapsing-Remitting
Amsterdam UMC, location VUmc296 enrolled1 locationNCT05296161